ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,955,696 | +9.4% | 75,248 | +20.4% | 0.01% | 0.0% |
| Q1 2024 | $1,787,672 | +1.6% | 62,506 | +8.7% | 0.01% | 0.0% |
| Q4 2023 | $1,759,684 | -3.0% | 57,506 | -14.8% | 0.01% | 0.0% |
| Q3 2023 | $1,813,887 | -9.7% | 67,506 | +19.9% | 0.01% | -12.5% |
| Q2 2023 | $2,008,479 | +40.4% | 56,323 | 0.0% | 0.01% | +33.3% |
| Q1 2023 | $1,430,604 | +58675.8% | 56,323 | -6.1% | 0.01% | -45.5% |
| Q4 2022 | $2,434 | +5.2% | 60,000 | -14.3% | 0.01% | 0.0% |
| Q3 2022 | $2,314 | -100.0% | 70,000 | -36.0% | 0.01% | -68.6% |
| Q2 2021 | $9,065,000 | +364.2% | 109,453 | +271.6% | 0.04% | +337.5% |
| Q1 2021 | $1,953,000 | -77.9% | 29,453 | -74.4% | 0.01% | -78.4% |
| Q4 2020 | $8,840,000 | +596.1% | 115,205 | +161.1% | 0.04% | +428.6% |
| Q1 2020 | $1,270,000 | -33.3% | 44,126 | +47.1% | 0.01% | -12.5% |
| Q4 2019 | $1,903,000 | -3.9% | 30,000 | -57.3% | 0.01% | -11.1% |
| Q3 2019 | $1,981,000 | +16.6% | 70,282 | +9.6% | 0.01% | +12.5% |
| Q2 2019 | $1,699,000 | – | 64,127 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |